A metabolic way to investigate related hurdles causing poor bioavailability in oral delivery of isoacteoside in rats employing ultrahigh‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry. (18th January 2017)

• Record Type: Journal Article
• Authors: Cui, Qingling; Pan, Yingni; Yan, Xiaowei; Qu, Bao; Liu, Xiaoqiu; Xiao, Wei
• Is Part Of: Rapid communications in mass spectrometry. Volume 31:Number 4(2017)
• Page Start: 371
• Page End: 380
• Publication Date: 2017-01-18
• Subjects: Mass spectrometry -- Periodicals; 543.65
• DOI: 10.1002/rcm.7795
• Languages: English
• ISSNs: 0951-4198

Abstract

Abstract : Rationale: Isoacteoside (ISAT), a phenylethanoid glycoside that acts as the principal bioactive component in traditional Chinese medicines, possesses broad pharmacological effects such as neuroprotective, antihypertensive and hepatoprotective activities. However, its pharmaceutical development has been severely limited due to the poor oral bioavailability. It is essential and significant to investigate related hurdles leading to the poor bioavailability of isoacteoside. Methods: Whole animal metabolism studies were conducted in rats, followed by metabolic mechanism including gastrointestinal stability, intestinal flora metabolism and intestinal enzyme metabolism employing the powerful method ultrahigh‐performance liquid chromatography combined with quadrupole time‐of‐flight tandem mass spectrometry (UPLC/QTOF‐MS/MS). Results: A simple, rapid and sensitive method has been developed which comprehensively revealed the underlying cause of poor bioavailability of ISAT in a metabolic manner. The prototype of ISAT and its combined metabolites have not been detected in plasma. Furthermore, the residual content of the parent compound in in vitro experiments was approximately 59%, 5% and barely none in intestinal bacteria, intestinal S9 and simulated intestinal juice at 6 h, respectively. Conclusions: The present work has demonstrated that the factors causing the poor bioavailability of isoacteoside should be attributed to the metabolism. In general, the metabolism that resulted from intestinal flora and intestinal enzymes were predominant reasons giving rise to the poor bioavailability of ISAT, which also suggested that metabolites might be responsible for the excellent pharmacological effect of ISAT. Copyright © 2016 John Wiley & Sons, Ltd.